Antidiabetic formulation and method
US7183321B2 · kind B2 · utility
2Cited by
19References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2001 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Dec 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.